Jules L Derks
Overview
Explore the profile of Jules L Derks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moonen L, Derks J, den Bakker M, Hillen L, van Suylen R, von der Thusen J, et al.
Mod Pathol
. 2024 Dec;
38(3):100677.
PMID: 39631518
Although most patients with pulmonary carcinoid (PC) can be cured by surgery, relapse may occur until 15 years after resection in up to 10% of patients. This is unpredictable at...
2.
Leunissen D, Moonen L, von der Thusen J, den Bakker M, Hillen L, van Weert T, et al.
J Thorac Oncol
. 2024 Nov;
PMID: 39581377
Introduction: Multi-omic studies have identified three molecular separated pulmonary carcinoid (PC) subgroups (A1, A2, B) with distinctive mRNA expression profiles (e.g., orthopedia homeobox protein [OTP], achaete-scute homolog [ASCL1], and hepatocyte...
3.
Derks J, Slikkerveer M, Janssen R, Rennenberg R
Ned Tijdschr Geneeskd
. 2024 Oct;
168.
PMID: 39474828
Background: Apricot seeds are recommended online for their alleged cancer-fighting and energy-boosting properties. However, they contain high levels of cyanogenic glycosides. Ingesting just a few apricot pits (1-3) can result...
4.
Moonen L, Derks J, Hillen L, van Suylen R, den Bakker M, von der Thusen J, et al.
Endocr Relat Cancer
. 2024 Jun;
31(9).
PMID: 38855984
The predictive value of the extent of peri-operative lymph node (LN) sampling in relation to disease relapse in patients with pulmonary carcinoid (PC) is unknown. Furthermore, post-surgery follow-up recommendations rely...
5.
Moonen L, Derks J, Lap L, Marijnissen B, Hillen L, den Bakker M, et al.
Transl Lung Cancer Res
. 2022 Dec;
11(11):2181-2191.
PMID: 36519022
Background: Orthopedia homeobox (OTP) has shown to be a useful prognostic marker to predict outcome in pulmonary carcinoids, which is also supported by the World Health Organization. However, the discontinuation...
6.
Moonen L, Mangiante L, Leunissen D, Lap L, Gabriel A, Hillen L, et al.
Int J Cancer
. 2022 Jan;
150(12):1987-1997.
PMID: 35076935
Limited number of tumor types have been examined for Orthopedia Homeobox (OTP) expression. In pulmonary carcinoids, loss of expression is a strong indicator of poor prognosis. Here, we investigated OTP...
7.
Derks J, Dingemans A, Speel E
J Thorac Oncol
. 2022 Jan;
17(2):e8-e10.
PMID: 35074235
No abstract available.
8.
Moonen L, Derks J, Dingemans A, Speel E
J Thorac Oncol
. 2022 Jan;
17(2):e21-e23.
PMID: 35074233
No abstract available.
9.
Hermans B, Derks J, Hillen L, van der Baan I, van den Broek E, von der Thusen J, et al.
Int J Cancer
. 2021 Oct;
150(5):802-815.
PMID: 34674268
Up to 14% of large cell neuroendocrine carcinomas (LCNECs) are diagnosed in continuity with nonsmall cell lung carcinoma. In addition to these combined lesions, 1% to 7% of lung tumors...
10.
Derks J, Rijnsburger N, Hermans B, Moonen L, Hillen L, von der Thusen J, et al.
J Thorac Oncol
. 2021 Jun;
16(10):1632-1646.
PMID: 34139363
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging clinical decision making. In this review, the following key clinical and pathologic issues and informative molecular markers are being discussed:...